Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy

Peritoneal Dialysis International

Volumn 16, Issue 2, 1996, Pages 158-162

  Haubitz, Marion ^a   Brunkhorst, Reinhard ^a   Wrenger, Eike ^a   Froese, Peter ^a   Schulze, Matthias ^a   Koch, Karl Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C reactive protein; End stage renal disease patients; Hemodialysis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; MALE; NORMAL HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

EID: 0029948951     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600213     Document Type: Article

References (35)

1. Dinarello CA. The biology of interleukin-1 and its relevance to hemodialysis. Blood Purif 1983; 1:197-224.
2. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purif 1983; 1:3-8.
3. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis of IL-1 and TNF by complement. Kidney Int 1990; 37:85-93.
4. Schindler R, Linnenweber S, Schulze M, et al. Gene expression of interleukin-1-β during hemodialysis. Kidney Int 1993; 43:712-21.
5. Lonnemann G, Bingel M, Koch KM, Shaldon S, Dinarello CA. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes.Lymphokine Res 1987; 2:63-70.
6. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. Nephron 1988; 50:273-6.
7. Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C, Bacle F, Delons S, Kazatchkine MD. In vivo induction of interleukin-1 during hemodialysis Kidraey Int 1989; 35:1212-18.
8. Haubitz M, Schulze M, Koch KM. Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 1990; 5:500-3.
9. Honkanen E, Grönhagen-Riska C, Teppo AM, Maury CPJ, Meri S. Acute-phase pro teins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes Nephron 1991;57:283-7.
10. Docci D, Bilancioni R, Buscaroli A, Baldrati L, Capponcini C, Mengozzi S. Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron 1990; 56:364-467.
11. Carozzi S, Nasini MG, Schelotto C, et al. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients. Trans Am Soc Artif Intern Organs 1990; 36:369-71.
12. Nakahama H, Tanaka Y, Shirai D, et al. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.Nephron 1992; 61:132-4.
13. Goldman M, Vandenabeele P, Moulart J, et al. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis Nephron 1990; 56:277-80.
14. Zemel D, ten Berge RJM, Koomen GCM, Struijk DG, Krediet RT. Serum interleukin-6 in continuous ambulatory peritoneal dialysis in patients (Letter).Nephron 1993; 64:320-1.
15. Moutabarrik A, Nakanishi I, Namiki M, Tsubakihara Y. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Clin Nephrol 1995; 43:243-8.
16. Shaldon S, Koch KM, Quellhorst E, Dinarello CA. Pathogeaesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs 1984; 30:193-4.
17. Zemel D, ten Berge RJM, Struijk DG, Bloemena E, Koomen GCM, Krediet RT. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. Clin Nephrol 1992; 37:97-103.
18. Floege J, Lonnemann G, Shaldon S, et al. Is tumor necrosis factor (TNF) produced in the peritoneal cavity of asymptomatic CAPD patients (Abstract)? Kidney Int 1989; 35:270.
19. Mariano F, Tetta C, Montrucchio G, Cavalli PL, Camussi G. Role of d1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients.Kidney Int 1992; 42:735-42.
20. Fieren MW, van den Bernd GJ, Bonta IL. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1β Prostaglandins Leukot Essent Fatty Acids 1992; 47:23-8.
21. Kimmel PL, Philipps TM, Phillips E, Bosch JP. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 1990; 38:129-35.
22. Lin CY, Lin CC, Husng TP. Serial changes of interleukin-6 and interleukin-8 in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 1993; 93:404-8.
23. Cannon JG, Dinarello CA. Increased plasma interleukin-1 activity in women after ovulation. Science 1985; 227:1247-9.
24. Cannon JG, van der Meer JWM, Kwiatkowski D, et al. Interleukin-1β in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res 1988; 7:457-67.
25. Chu CT, Pizzo SV. Interactions between cytokines and alpha 2-macroglobulin. Immunol Today 1991; 12:249.
26. Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161:79-84.
27. Sethi D, Muller BR, Brown EA, Maini RN, Gower PE. C-reactive protein in haemodialysis patients with dialysis arthropathy. Nephrol Dial Transplant 1988; 3:269-71.
28. Claus DR, Osmand AP, Gewurz H. Radioimmunoassay of human C-reactive protein and levels in normal sera. J Lab Clin Med 1976; 87:120-8.
29. Lonnemann G, Koch KM, Shaldon S, Dinarello CA. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. J Lab Clin Med 1988; 112:76-86.
30. 559 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol 1987; 82:317-20.
31. Bingel M, Lonnemann G, Koch KM, Shaldon S, Dinarello CA. Human interleukin-1 production is enhanced by sodium acetate. Lancet 1987; i:14-16.
32. Bingel M, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Human interleukin-1 production during hemodialysis. Nephron 1986; 43:161-3.
33. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 1988; 33:29-35.
34. Topley N, Mackenzie R, Jörres A, Coles GA, Davies M, Williams JD. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity. Perit Dial Int 1993; 13(Suppl 2):282-5.
35. Brunkhorst R, Wrenger E, Krautzig S, Ehlerding G, Mahiout A, Koch KM. Clinical experience with home automated peritoneal dialysis. Kidney Int 1994; 48:S25-30.